Arrayit Corporation
524 East Weddell Drive
Sunnyvale, CA 94089
USA
Phone 408-744-1331
FAX 408-744-1711
Email arrayit@arrayit.com
Web www.arrayit.com

Corporate Newsletter
Click here to sign up for the Arrayit newsletter.

Recent News
8/23/10 Arrayit Corporation Announces Premarket Approval (PMA) Submission Strategy for OvaDx®.
8/15/10 Arrayit Corporation Adds 128 New Products to Its Life Sciences Tools Portfolio.
7/29/10 Arrayit Corporation Taps Former IVAX Diagnostics Executive to Build Strategic Partnerships.
6/30/10 Arrayit Corporation Receives Registered Trademark for OvaDx®.
6/16/10 Arrayit Corporation Technology May Provide Vital Clues to Detoxification of the Oceans.
5/10/10 Arrayit Corporation Reports Strong Surge in Customer Demand for the Company's Leading Edge Life Sciences Microarray Instruments.
4/20/10 Arrayit Corporation to Present at Southern California Investment Association Summer Capital Conference.
4/15/10 Arrayit Achieves Significant Progress in First Quarter 2010.
3/22/10 Arrayit Corporation Taps DOCRO, Inc. to Facilitate FDA Approval of OvaDx.
3/15/10 Arrayit Corporation Completes Installation of Patented Manufacturing Technology in Russia.
2/24/10 Arrayit Corporation President Dr. Mark Schena to Appear Live on the Television Program the Big Biz Show.
2/18/10 Arrayit Corporation Has Discovered a Pathway to True Health Care Reform With Pre-symptomatic Diagnostics.
2/4/10 Arrayit Wins Landmark DNA Testing Patent in Israel.
1/25/10 Arrayit Corporation's Proteomic Biomarkers Clear the Way for Pre-Symptomatic Detection of Ovarian Cancer and Other Major Diseases.
1/19/10 Arrayit Corporation Selected by Silicom Ventures to Present at the 2010 Personalized Medicine World Conference in Silicon Valley.

More News
1/7/10 Major News Media Missed the Mark -- There Is a New Pre-Symptomatic Screening Test for Ovarian Cancer Coming From Arrayit Corporation, and It Will Be Available Soon.
12/22/09 Arrayit Corporation Announces Manufacturing Breakthrough.
12/17/09 Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010.
12/10/09 Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation.
12/9/09 Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics.
11/30/09 Arrayit Diagnostics Names Elite Financial Communications Group as Investor Relations/Public Relations Counsel.
11/18/09 Arrayit Technology Purchased by Johns Hopkins University to Study Rheumatoid Arthritis.
11/12/09 Arrayit Diagnostics Focused on Early Stage Disease Detection.
11/5/09 Arrayit Corporation to Diagnose Early Stage Cancers and Monitor Effectiveness of Treatments.
11/2/09 Arrayit Corporation Blood Tests Diagnose Early Stage Cancers and Communicable Diseases.
10/28/09 Arrayit Announces NanoPrint Sale to Leukemia Center in Poland.
10/22/09 Arrayit and the USDA Join Forces to Protect America's Crop Plants.
10/15/09 Will Arrayit Technology Identify Life on Mars?
10/7/09 Arrayit Corporation CEO Reports to Shareholders.
10/5/09 Arrayit Deploys Next-Generation Proteomics Platform.
9/28/09 Arrayit Wins Contract With Austrian Institute of Technology for Detection of Highly Dangerous Pathogens.
9/21/09 Arrayit Wins Equipment Contract From Sandia National Laboratories.
9/16/09 Arrayit Wins Manufacturing Contract From the Centers for Disease Control.
9/10/09 Arrayit Offers Million Dollar Biomarker Discovery Service.
9/02/09 Arrayit Lands Patent for Population Scale Diagnostics in World's Most Populous Country.
8/27/09 Arrayit Speeds Allergy Testing.
8/12/09 Arrayit Corporation Opens International Marketing Headquarters in Houston.
7/23/09 Arrayit Corporation Announces Worldwide Product Sales Up Nearly 50%.
7/16/09 Arrayit Corporation and Parkinson's Institute Implement New Screening Techniques for Identification of Molecular Biomarkers.
6/24/09 Mark Schena, PhD, Positions Arrayit Corporation to Enter Molecular Diagnostics Using VIP Technology.
6/18/09 Arrayit Corporation addresses flu pandemic.
4/7/09 Arrayit Corporation and The Parkinson's Institute announce new research collaboration.
3/19/09 Arrayit begins trading as ticker symbol ARYC.
1/15/09 Arrayit extends worldwide licensing of its patented high-throughput genotyping platform.